Know About Pharmaceuticals
The US is a gateway from just about anywhere on the globe for pharmaceutics. While this offers an opportunity for a variety of options, it also presents a staggering challenge for the security forces to protect us from related vulnerabilities. Considering the complexities of the global prescription supply system, safeguarding the quality of our domestic production of medicines is more critical than ever.You may want to check out Tips on Starting a Pharmacy | Fit For The Soul for more.
We ‘re seeking to welcome the potential of this growing global economy while preserving American citizens’ health and safety. India and China are known to have less robust pharmaceutical regulations than the US, according to the Senate Committee on Health , Education, Labor and Pensions, yet they play a major role in providing the US with 80 per cent of the active ingredients used in US-made drug products. There are currently more than 150 nations interested in providing the US with active materials. However, a massive 40% of the completed prescription items that line our pharmacy cabinets come from overseas, and this development is expected to continue into the future.
The main cause for alarm as seen in the horrific deaths in 2007 of 150 patients who were related to the usage of tainted heparin. Keeping international product distributors to the same requirements as American distributors is important in order to even out the playing field and help protect customers.
Securing the pharmacy supply chain was at the forefront of a briefing conducted by the United States Senate Committee on Health Care Jobs and Pensions on September 14, 2011. It was acknowledged that with the the complexities of the supply chain, “authorities have not kept up with the demands of the new global marketplace” and that “these aspects pose significant difficulties for FDA and industry in ensuring that all products are of good quality and move securely through their diverse supply chains.”
There is an apparent need for stronger health and compliance controls to better protect the purity and consistency of medicines entering the US. Video recordings of the September 14th hearing and access to detailed testimonies of witnesses are accessible on the Senate Committee website for more in-depth material.